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ABSTRACT 
The lnfluence of mlcrosomal and nuclear aryl hydrocar-
bon hydroxylase (AHH) actlvlty on the covalent blndlng of 
[G·3H]benzo(a )pyrene to rat llver DNA was evaluated in 
viWJ. lnductlon of mlcrosomal AHH was obtalned alter 
phenobarbltal treatment (160% of control), whlch also 
lncreased DNA blndlng to 190%, but left the nuclear 
actlvlty unchanged. Nuclear AHH was lnduced wlth dlel-
drln (150%), and the blndlng was decreased to 75%, 
whereaa the mlcrosomal AHH was at control Ievei. The 
lncreaslng effect of mlcrosomal AHH lnductlon as weil as 
the decreaslng effect of nuclear AHH lnductlon on the 
blndlng was shown clearly when the data of the Individual 
rata were uaed to solve the equatlon 
Binding = e•(mlcroeomal AHH) + b•(nuclear AHH) + c 
Multiple linear regresslon analysls wlth the data from 10 
anlmala reaulted ln positive valuea for a and c, a negative 
value for b, and a good multiple correlatlon coefflclent of 
r = 0.974. Pretreatment wlth 3-methylcholanthrene ln· 
duced mlcrosomal AHH to 380% of control and nuclear 
AHH to 590% and lncreased the blndlng' to 175,.-o. The 
blndlng was hlgher than predlcted by the formula found, 
probably because the lncreaslng lnfluence of lnduced 
mlcrosomal AHH overahadowed the decreaslng effect of 
the nuclear AHH. The study ahows clearly that the blndlng 
of a forelgn compound to DNA in viWJ Ia dependent not 
only on mlcrosomal enzyme actlvltles but also on nuclear 
actlvltles even lf the latter are conslderably lower than 
thoae of mlcrosomes. 
INTRODUCTION 
The mixed-function oxygenase AHH2 (EC 1.14.14.2), an 
inducible enzyme system found in most mammalian tissues, 
catalyzes the metabolism of BP and other carcinogenic 
PAH to products that can bind covalently to DNA (6, 7, 13). 
This binding to DNA is accepted as an early and critical 
event in chemical carcinogenesis, and it has been shown 
that the carcinogenic potency of different PAH is correlated 
to the extent of their binding to DNA (2, 3). 
The tumor incidence from exposure to PAH is affected by 
1 Part of this work has been presented at the 10th Annual Meeting of the 
Union of the Swlss Societlea for Experimental Blology, Davos, Swltzerland, 
May 19 to 20, 1978, and at the 20th Congresa of the European Society of 
Toxlcology, Berlln, GFR, June 25 to 28, 1978. 
1 The abbrevlatlons used are: AHH, aryl hydrocarbon hydroxylase; BP, 
benzo(a)pyrene; PAH, potycycllc aromatlc hydrocarbons; MC, 3-methylchol· 
anthrene; 01, dieldrln; NaP, sodlum phosphate buffer, pH 6.8; EH, epoxlda 
hydratue. 
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other compounds, and there are indications that this is due 
to an alteration of the PAH metabolism, particularly to 
changes in AHH activity (1, 10, 15). The first aim of this 
study was therefore to determine whether an induction of 
AHH has any influence on the binding of BP to DNA in vivo. 
ln the liver cell, AHH is located in the endoplasmic 
reticulum and, with much less activity, in the outer nuclear 
membrane (15, 17). 8oth microsomal and nuclear AHH's 
are capable of activating BP to DNA-binding metabolites, 
and an induction in general increased the binding in vitro 
(1, 8, 15, 16). The extent of induction of AHH was found to 
be different in the 2 compartments and tobe dependent on 
the inducer used (8, 15, 18). 
A study of the time dependence of the AHH induction 
revealed different induction Ieveis in microsomes and nu-
clei in the first days of the treament, with an equilibration of 
the induction Ieveis after a Ionger time period (18). This 
finding enabled us to evaluate in vivo the roJe of microsomal 
or nuclear AHH in the activation of BP to ONA-binding 
metabolites. 
MATERIALS AND METHODS 
Chemlcals. BP, MC, and Dl were obtained from Fluka 
AG, Buchs, Switzerland, and Mazola corn oil was from 
Maizena GmbH, Hamburg, Germany. [G-3 H]BP with a spe-
cific activity of 24 Ci/mmol was from the Radiochemical 
Centre, Amersham, England. BP was purified further by 
column chromatography in hexane on silica gel, and 01 was 
purified by recrystallization. Sodium phenobarbital was 
obtained from the Kantonsapotheke, Zurich, Switzerland. 
Hydroxyapatite (Bio-Gel HTP) was purchased from Bio-Rad 
Laboratories, Richmond, Calif. 94804. 
Anlmals. Adult male rats (Sprague-Dawley derived SIVSO, 
Kantonales Tierspital, Zurich, Switzerland), weighing 280 to 
330 g at the day of sacrifice, were housed 2 per cage on 
sawdust in clear plastic cages and held untreated for at 
least 1 week after receipt. Each pair of ratswas given the 
same treatment. Nafag Iabaratory chow (Nafag AG, Gossau, 
Switzerland) and tap water were provided ad libitum. 
Enzyme lnductlon. lnducers were administered as de-
scribed (18). PB was given in the drinking water at 1 g per 
Iiter of sodium phenobarbital. MC and 01 (20 mg/kg) in corn 
oil were injected i.p. daily. 
Administration of Trltlated BP. ln Experiment A, ( G-'H] 8 P 
was diluted with inactive BP to a specific activity of 1.44 Ci/ 
mmol. Twenty hr before sacrifice, a solution of 250 1'9 BP 
per ml corn oil (2 ml/kg) was injected i.p. (500 1'9 BP/kg; 
6.3*10• dpm/kg). This dose does not induce the AHH (11 ). 
ln Experiment 8, (G-3H]BP was diluted to a specific activity 
of 4.9 Ci/mmol and 700 1'9 were dissolved in hexane and 
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dispersed as a fine film in a 50-ml round-bottomed flask by 
rotary evaporation of the hexane. Ten ml of serum from the 
same strain of rats were added, and the flask was filled with 
nitrogen and vigorously shaken in the dark at room temper-
ature for 48 hr. Complete dissolution of the 8 P was checked 
by spectrophotometry and liquid scintillation counting of 
the supernatant of a diluted serum sample centrifuged at 
105,000 x g for 20 min. Sixteen hr before sacrifice, the rats 
were constrained in a plastic bottle, and 2 mllkg (140 1'9 
BP/kg; 6.0*10• dpm/kg) were injected into the penis vein 
without anesthesia. 
Determination of AHH Actlvlty. Animals were killed by 
stunning and cervical dislocation at 0800 hr. The liver was 
excised and washed twice in ice-cold 0.25 M sucrose, 50 
mM Tris-HCI, pH 7.5. liver microsomes and nuclei were 
prepared, as described (18), by a calcium precipitation 
method and sucrose density centrifugation, respectively. 
AHH activity was determined with an assay based upon the 
fluorescence of hydroxylated BP products as described 
before (18). 
Isolation and Purlflcatlon of DNA. The big lobe from the 
washed liver was frozen in liquid nitrogen and stored 5 days 
until further use. The DNAwas isolated according to Markov 
and lvanov (12) with several modifications. 
Four g of tissue were blended with 25 ml of 8 M urea, 0.24 
M sodium phosphate {hereafter known as urea buffer) 
containing 1% sodium dodecyl sulfate and 10 mM EDTA in 
a custom-made, air-tight aluminum headpiece on a Waring 
Blendor at high speed for 4 times 30 sec with intervals of 30 
sec to cool the headpiece in an ethanol bath {-30"). The 
foamy lysate was centrifuged for 3 min at 3000 x g, and 10 
ml of chloroform/isopentyl alcohol/phenol 24/1/25 were 
added. The mixture was vigorously shaken for 10 min at 
room temperature and centrifuged for 15 min at 20,000 x g. 
The aqueous supernatant was pipetted off, and the extrac-
tion step was repeated. To remove the phenol, the super-
natant was extracted twice with 25 ml of diethyl ether. For 
the DNA adsorption by hydroxyapatite chromatography, 3 g 
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of dry hydroxyapatite were suspended in urea buffer, stored 
overnight at room temperature, poured into a column of 2.5 
cm diameter, and equilibrated with three bed volumes of 
urea buffer. The column was loaded with the aqueous 
sample and washed with urea buffer with a flow rate of 1 
mllmin by gravity until no absorption at 260 nm was 
recorded (70 ml). The same flow rate was maintained for 
the removal of the urea with 25 ml'of 14 mM NaP. DNA was 
eluted with 0.48 M NaP, monitored by spectrophotometry at 
260 nm. The ONA fraction was d ialyzed against 500 vol um es 
of deionized water for 16 hr at 4° and made 0.2 M with 
respect to NaCI by adding 2 M NaCI. Two volumes of 
ethanol were added, and the ONA -was precipitated at -20" 
for 24 hr. After centrifugation for 20 min at 1000 x g, the 
supernatant was decanted, and the DNA was dried in a 
vacuum desiccator and redissolved in 14 mM NaP. 
The amount and purity of the DNA was determined by 
spectrophotometry. An absorbance of 6.18 at 260 nm was 
established for 1 l'mol DNA-phosphate per ml by phosphate 
determination following Chen et al. (4). The purity of the 
final preparation was at least equal to the one specified by 
Markov and lvanov {12) as judged by the ratio A 260 nm/ A 
230 nm, which was better than 2.30 (0.1% protein). 
One to 2 mg dried DNA were redissolved in 4 ml of 14 mM 
NaP, and the radioactivity was counted in a BF 5000 
scintillation counter (Laboratorium Berthold, Wildbad, Ger-
many) after the addition of 10 mllnsta-Gel (Packard Instru-
ments Co., Downers Grove, 111. 60515). The net counts 
ranged from 17 to 180 cpm. 
RESULTS 
The binding of BPto rat liver ONA after AHH induction by 
different inducers is given in Table 1, together with the 
corresponding AHH activities in microsomes and nuclei. 
Experiment A: l.p. Admlnlatratlon of Trltlated BP. Four-
teen-day pretreatment with PS markedly enhanced the 
microsomal AHH activity and doubled the amount of BP 
Table 1 
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Binding of tritiated BP to rat liver DNA afterdifferent inductlon of microsomal and 
nuclearAHH 
Adult male rats were treated with an inducer for the time period indicated until 
sacrifice. ln Experiment A, 500 1'9 BP per kg in corn oil were administered p.o. 20 hr 
before sacrlfice. ln Experiment B, 140 1'9 BP per kg in serum were injected i.v. 16 hr 
before sacrlfice. AHH activity ls expressedas pmol 3-0H-BP formed in 1 min per mg of 
proteln, measured by a fluorimetric assay; binding to ONA as ~&mol BP bound per mol 
ONA-phosphate/mmol BP adminlstered per kg body weight. 
lnducer dosages: phenobarbital, given continuously in the drinking water at 1 g/liter; 
01,20 mg/kg in corn oll for 3 consecutive days; MC, 20 mg/kg/day in com oll; control, no 
pretreatment. 
Experiment A inducer 
None (control) 
Phenobarbltal, 14 days 
01, 12 days 
Experiment 8 inducer 
None (control) 
Phenobarbital, 8 days 
01,3 days 
MC, 4days 










39 :t 6 
44 :t 26 
48:15 
24± 0 
26 ± 3 
37 ± 4b 
140 ± 22b 
6 Slgniflcantly different from control (p < 0.05; Student's t test). 
Binding to ONA 
6.8:0.8 
14.2 ± 8.4 
7.2 ± 1.9 
8.7± 3.5 
16.9 ± 3.06 
6.6: 3.1 
15.2 ± 2.36 
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bound to ONA. 01 did not alter the binding, although the 
microsomal activity was also elevated. Neither of the in-
ducers affected the nuclear AHH activity, but there was a 
tendency to higher activity seen after 01 treatment. One 
might tentatively conclude from these data that the increase 
in binding observed after the induction of microsomal AHH 
is counteracted by increases in nuclear activity. 
This hypothesis is corroborated when the data of individ-
ual animals are considered. Chart 1 shows, in a 3-dimen-
sional plot, the dependence of the binding on the micro-
somal and nuclear AHH activities. One block represents the 
values from 1 animal. 
With such a representation, the reducing effect of nuclear 
AHH on the binding of BP to DNA comesout much more 
clearly, and the data fit into a linear equation of the form 
Binding = +0.0071*(microsomal AHH) 
- 0.36*(nuclear AHH) + 6.1 
with a surprisingly good multiple correlation coefficient r = 
0.82 and a standard error of the estimation of the binding of 
3.8 units. 
This set of experiments prompted us to continue the 
investigation with some minor modifications. A different 
administration schedule was used for BP and 01. MC, a 
potent inducer of both the microsomal and nuclear AHH, 
was included. 
The dose of tritiated BP was lowered to 140 "'g/kg. This 
was done to exclude any inducing effect from BP itself. 
Previous experiments had shown that an induction of AHH 
is seen only above a single i.p. dose of 1 mg BP/kg (11). 
BP was injected i.v. in order to aceeierate distribution 
and metabolism of BP so that the time between administra-
tion and sacrifice could be reduced to 16 hr. 
Experiment B: t.v. Administration of Trltlated BP. Phen-
obarbitol pretreatment had the same enhancing effect on 
microsomal AHH and binding as found in Experiment A 
(Table 1). With 01, the microsomal AHH was not changed, 
but the induction of nuclear AHH was significant this time. 
We found the expected decrease in binding, which is on a 
nonsignificant Ievei on the basis of the average data but 
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Chart 1. Binding of BP to rat liver DNA as a function of the microsomal 
and nuclear AHH activity a8 obtained in Experiment A. Each bar represents 
the 3 values from one individual rat treated as indlcated (inducer and days of 










..P •• #' 
..,., / 
~~ , • .s-•. 
Chart 2. Binding of BP to rat liver DNA as a function of the microsomal 
and nuclear AHH activity as obtained in Experiment 8. Each bar reprasents 
the 3 value8 from one individual rat traated a8 indicated (inducer and day8 of 
pretreatment). See legend to Table 1 for further explanations. 
very obvious with the individual animal data as seen in 
Chart 2. Linear regression analysis of the values used in 
Chart 2 resulted in the equation 
Binding = +0.014*(microsomal AHH) 
- 0.39*(nuclear AHH) + 5.7 
with a multiple correlation coefficient r = 0.974 and a 
standard error of the estimation of 1.5 units. The plain 
fitting was therefore even better than that from the i.p. 
Experiment A. 
Pretreatment of the animals with MC gave rise to highly 
significant inductions of microsomal and n"uclear AHH ac· 
tivities. The high binding values obtained after this experi-
ment make it clear that the increasing effect of m icrosomal 
induction on the binding overshadows the decreasing influ-
ence of nuclear induction. 
One might calculate theoretical binding values for the 
MC-treated animals from their AHH activities on the basis of 
the formula found by linear regression. They come out 
much lower than the ones actually measured, and even 
come out negative. This indicates that the theoretical plane 
formula for the binding as a function of the 2 AHH activities 
is not linear for the expanded scale of Chart 3, which 
combines all data of Experiment B. 
lt is tobe noted that MC does not induce the same AHH 
species as phenobarbitol or 01 does. ln particular, other 
types of cytochrome P450 are formed (15, 16). 
DISCUSSION 
The data presented show that the microsomal AHH in-
creases the amount of binding of BP to DNA in vivo, 
whereas the nuclear AHH decreases it. These findings were 
somewhat unexpected, since our working hypothesis was 
that the nuclear AHH, which is closer to the DNA than the 
microsomal AHH, should have an increasing effect on ONA 
binding. Rather, it could now be concluded that the activa-
tion of BP to reactive metabolites that can bind covalently 
to ONA takes place in the microsomal fraction, and that the 
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Chart 3. Binding of BP to rat liver DNA as a function of the microsomal 
and nuclear AHH activity as obtained in Experiment B. Data from rats 
pretreated wlth MC are included. Each bar represents the 3 values from one 
individual rat treated as lndlcated (inducer and days of pretreatment). See 
legend to Table1 for further explanations. 
comparatively low activity of nuclear AHH inactivates these 
metabolites through further oxidation. 
lt is to be noted, however, that the AHH is not the only 
enzyme involved in the process leading to reactive metabo-
lites that can covalently bind to DNA.In particular, EH plays 
an important role in the activation of BP by forming BP-
dihydrodiols from BP-epoxides, which are then further 
oxidized by the AHH to the very reactive BP-diolepoxides 
(14, 16, 21). EH is inducible by various compounds in 
microsomes and nuclei (14). An induction of EH by the 
chemieals used in this study could aceeierate the interme-
diate step in the formation of the BP-diolepoxides and 
could therefore increase the binding of B P to DNA. On the 
other hand, reactive epoxides are, on their own right, 
Substrates for EH, and are inactivated to BP-dihydrodiols 
and tetrahydrotetrols. An induction of EH might therefore 
lower the binding. There are no data available to date to 
decide whether this enzyme would produce a positive or 
negative change in our in vivo study. 
Additional detoxifying enzyme activities which are also 
inducible are present in microsomes and nuclei (5, 9, 20). 
Glutathione-S-epoxide transferase, 3'-phosphoadenosine 
5'-phosphosulfate sulfotransferase, and glucuronyl trans-
ferase are known to inactivate BP metabolites, and they 
may also contribute to alterations in the binding of BP to 
DNA when changed in their activity by an inducer. 
Long-term treatment with inducing agents results in an 
equallevel of AHH induction in microsomes and nuclei (18). 
The binding of BPto DNAwould then be enhanced because 
the increasing effect of the microsomal AHH outweighs the 
decreasing influence of the nuclear AHH. Such a Situation 
is typical for an exposure of humans to environmental 
agents, and our animal model predicts increased binding to 
DNA and tumor formation under these circumstances. 
Wattenberg and Leong (19) performed such an experi-
ment with mice, where a 16-day pretreatment with 5,6-
benzoflavone induced lung AHH and resulted in a decrease 
in lung tumor formation from orally administered BP. This 
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finding cannot be explained on the basis of our experiments 
with rats. 
Kouri (1 0) showed that there is a correlation between 
Ieveis of AHH activity and susceptibility to BP-induced lung 
cancer in various strains of mice. Moreover, after pretreat-
ment of the mice with 2,3,7,8-tetrachloro-dibenzo-p-dioxin, 
an AHH inducer similar to MC, he observed a doubling of 
the lung cancer occurrence. 
These findings with experimental animals show that we 
still Iack a scientific basis for a prediction of human cancer 
incidence after exposure to inducing agents. Many more in 
vivo experiments are needed before any further conclusions 
can be d rawn. 
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